Results 91 to 100 of about 225,386 (188)

Plasma exchange therapy for severe graves' ophthalmopathy

, 1986
In the present studies, the authors report on the treatment of nine Graves' disease patients with severe ophthalmopathy by use of intensive plasma exchange followed by immunosuppression (during three to six months). Results of treatment were evaluated by
Winand, René, Schrooyen, Marc, Glinoer, Daniel   +2 more
core   +1 more source

Antioxidant agents in the treatment of Graves' ophthalmopathy

, 2000
PURPOSE: To report the effect of antioxidant agents in the treatment of mild and moderately severe Graves' ophthalmopathy. METHODS: Prospective, nonrandomized, comparative study performed at a referral center.
Bouzas, E.A., Koutras, D.A., Mastorakos, G., Karadimas, P.   +3 more
core   +1 more source

Orbital radiotherapy for Graves' ophthalmopathy

, 2002
Orbital radiotherapy is a well-established method of treatment for severe Graves' ophthalmopathy because of its anti-inflammatory and locally immunosuppressive effects. It has been used for 60 years.
PINCHERA A., ROCCHI R, MARCOCCI C, TANDA, MARIA LAURA PIERA, BARBESINO G, BARTALENA, LUIGI, MAZZI B   +6 more
core   +1 more source

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study

Ophthalmology and Therapy
Introduction Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves’ disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual ...
Grace Chia-Yen Hsu, Shyang-Rong Shih, Fang-Yu Chang, Shu-Lang Liao, Yi-Hsuan Wei   +4 more
doaj   +1 more source

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Increased retinal blood flow in patients with active Graves' ophthalmopathy

, 2007
PURPOSE: To investigate retinal blood flow by Heidelberg retina flowmeter in patients with active Graves' ophthalmopathy. MATERIALS AND METHODS: Thirty patients with active Graves' ophthalmopathy in euthyroid state and thirty normal controls were ...
Costagliola, Ciro, CAMPA, Claudio, INCORVAIA, Carlo, SEBASTIANI, Adolfo, PERRI, Paolo, Costagliola C., D'ANGELO, Sergio   +6 more
core   +1 more source

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

Treatment of ophthalmopathy in the course of Graves’ disease

Journal of Education, Health and Sport, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Magdalena Woźniak, Ewa Tywanek, Grzegorz Rudzki, Joanna Świrska, Agnieszka Zwolak, Robert Jan Łuczyk   +5 more
doaj  

Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Yeung A, Siddiqui MS, Mirtorabi N, Ahmed UN, Watts E, Sharma N, Kumari R, Boelaert K, Muzaffar J, Nieto H.   +9 more
europepmc   +1 more source